Stock Alert: Precigen Climbs 20% As Merck Increases Stake In The Co.

By RTTNews Staff Writer   ✉   | Published:

Shares of Precigen, Inc. (PGEN) jumped about 20% on Friday morning after the company said Merck has increased stake in the company.

PGEN is currently trading at $5.29, up $0.88 or 19.95%, on the Nasdaq.

Precigen said existing shareholder Merck KGaA, through its wholly owned subsidiary Ares Trading S.A., has elected to voluntarily convert a convertible note with an outstanding principal balance of $25 million to increase its stake in Precigen from about 11.6% to 14.8%.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Walt Disney Co. is reorganizing its media and entertainment businesses aiming to accelerate its direct-to-consumer or DTC strategy following the significant success of its streaming service Disney+. In a statement, the company stated that its media and entertainment businesses will be separated into creative engines, as well as Media and Entertainment Distribution Group. Johnson & Johnson (JNJ) has paused the phase III study of its COVID-19 vaccine candidate, JNJ-78436735, due to an unexplained illness in a study participant, Stat News reported, citing a document sent to outside researchers running the 60,000-patient clinical trial. Twitter has taken additional steps to prevent any manipulation or interference in the upcoming U.S. Elections or other civic processes through misleading Tweets. It announced significant product and enforcement updates to enable the smooth conduct of the democratic process. The social media platform has recently expanded its civic integrity policy to address misleading information.